68Ga-NOTA-AE105
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 68Ga-NOTA-AE105, covering 2015-08-24 to 2022-06-30. Get the full timeline:
Most recent: Clinical Trial Update: PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105 [Phase 2]